Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-26-005496
Filing Date
2026-05-04
Accepted
2026-05-04 16:14:14
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6943
  Complete submission text file 0001214659-26-005496.txt   8671
Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9792
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 26937757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)